3 articles, transcripts, and reports
Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) Q3 2020 Earnings Call dated Nov. 02, 2020 Corporate Participants: Lisa M. Wilson — Investor Relations – In-Site Communications, Inc. Scott Tarriff — Founder,…
Eagle Pharmaceuticals Inc (EGRX) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Lisa Wilson — Investor Relations Scott Tarriff — Founder, Chief Executive Officer and Director Pete…
— Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) reported its fourth-quarter 2019 adjusted earnings of $0.48 per share versus $0.46 per share expected. — Total revenue fell…
